• Explore /
  • Poster
  • / Capture of common adverse events (AEs) by patient-reported outcome measures (PROMs) used in clinical trials of immuno-oncology (IO)-based combination therapies in advanced renal cell carcinoma (aRCC).

Capture of common adverse events (AEs) by patient-reported outcome measures (PROMs) used in clinical trials of immuno-oncology (IO)-based combination therapies in advanced renal cell carcinoma (aRCC).

Abstract Poster

Authors

null

Stephen Huo

Bristol-Myers Squibb Research, Princeton, NJ

Stephen Huo, Flavia Ejzykowicz, Andrew Delgado, Karen D. Beauchamp

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Cost, Value, and Policy,Health Care Access, Equity, and Disparities,Patient Experience

Sub Track

Integrating Patient Experience Assessment and Patient Reported Outcomes Into Practice

Citation

J Clin Oncol 40, 2022 (suppl 28; abstr 263)

DOI

10.1200/JCO.2022.40.28_suppl.263

Abstract #

263

Poster Bd #

G2

Abstract Disclosures

Similar Posters

First Author: David Cella

First Author: Elaine Chang

First Author: Nusrat Jahan

First Author: Gabriel Roman Souza